The porphyria therapies market is projected to grow at an annualized rate of 10.97% during the period 2021-2030, claims Roots Analysis | #Porphyria # Porphyria market # Porphyria pipeline # Porphyria treatment # Porphyria treatment market

The porphyria therapies market is projected to grow at an annualized rate of 10.97% during the period 2021-2030, claims

North America has emerged as a key hub for the development of porphyria therapies, featuring the presence of 65% developers.

The light activated therapies market is anticipated to grow at an annualized rate of 27.7% till 2030 | #Photodynamic therapy # Photothermal therapy # light activated cancer therapies # light therapy

The light activated therapies market is anticipated to grow at an annualized rate of 27.7% till 2030

Rising prevalence of skin disorders is expected to promote the adoption of light activated therapies, making it one of the relatively faster growing segments of this industry.

DNA DAMAGE RESPONSE TARGETING THERAPEUTICS (BEYOND PARP INHIBITORS) - CURRENT MARKET LANDSCAPE | #DNA damage # DDR Therapeutics # DNA targeting # PARP inhibitors

DNA DAMAGE RESPONSE TARGETING THERAPEUTICS (BEYOND PARP INHIBITORS) - CURRENT MARKET LANDSCAPE

There has been a significant increase in the number of developers that have been established in this domain post-2008.

OVER THE YEARS, DIGITAL THERAPEUTIC SOLUTION DEVELOPERS HAVE STARTED DEVELOPING PRODUCTS THAT CATER TO NOVEL TARGET INDICATION(S) | #Digital Health # Digitization # Therapeutics # Diagnostics # Monitoring # Market

OVER THE YEARS, DIGITAL THERAPEUTIC SOLUTION DEVELOPERS HAVE STARTED DEVELOPING PRODUCTS THAT CATER TO NOVEL TARGET INDI

This can be attributed to the fact that these therapeutic areas have highest number of solutions under development.

IN PURSUIT OF A COMPETITIVE EDGE, STAKEHOLDERS ARE ACTIVELY EXPANDING THEIR EXISTING CAPABILITIES TO ENHANCE THEIR RESPECTIVE OFFERINGS AND COMPLY WITH EVOLVING INDUSTRY BENCHMARKS | #cell and gene therapy bioassay services # cell and gene therapy bioassay # gene therapy assay # cell therapy assay

IN PURSUIT OF A COMPETITIVE EDGE, STAKEHOLDERS ARE ACTIVELY EXPANDING THEIR EXISTING CAPABILITIES TO ENHANCE THEIR RESPE

In this analysis, we have compared more than 40 bioassay service providers offering services for cell and gene therapies across multiple parameters.